At the BIO 2026 convention, Avance Clinical announced a significant expansion of its operations across Asia Pacific and China, enhancing its role as a leading Contract Research Organization (CRO) for biotechnological companies. The company is now extending its presence to Singapore, Malaysia, and mainland China, while scaling its operations in India, addressing the growing demand for diverse patient access and accelerated clinical trials in these regions. Avance Clinical aims to offer an integrated and seamless delivery model, leveraging its robust regulatory expertise and site relationships to facilitate multi-country trials. Executives from the company will showcase these capabilities at the convention, discussing strategies for patient enrollment and global development timelines.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://biopharmaapac.com/news/92/8080/avance-clinical-expands-apac-and-china-operations-to-accelerate-global-biotech-trials.html
